Location: Lymphoid tissue
Behaviour: Depends on form of lymphoma
Diagnostics: (immuno)cytology/histology, flowcytometry, PARR
Treatment: Chemotherapy, prednisolone, (radiotherapy)
Prognosis: Variable: 1 month to cure (depends on the form of lymphoma and treatment)
There are no pictures available for this tumour type
  1. Vail MV, Pinkerton ME, Young KM. Hematopoetic tumours. Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition, Chapter 32 (p 608-627).
  2. Vail DM, Pinkerton M, Young KM. Hematopoetic tumors. Withrow and MacEwen's Small Animal Clinical Oncology, 6th edition, Chapter 33 Withrow (p 688-711).
  3. Valli VE, et al. Classification of Canine Malignant Lymphomas According to the World Health Organization Criteria. Vet Pathol 2011;48(1):198-211.
  4. Marconato L, et al. Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers. Journal for ImmunoTherapy of Cancer (2019) 7:146.
  5. MacEwen EG, et al. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma. J Vet Intern Med . 1992 Jul-Aug;6(4):230-4.
  6. Mcvoordieren: Oncaspar hond en kat
  7. Jeffreys et al 2005, JAAHA, 41: 221-226
  8. MacDonald et al, 2005, Vet intern Med 19:732-736
  9. Valli et al, 2006, Vet Pathol 43(3):241-56
  10. Flood-Knapik et al 2013, Vet Comp oncol 11(4): 272-286
Clinical trials

Centre Hospitalier Vétérinaire Frégis
Arcueil, France
+33 1 49 85 83 00